Publications by authors named "Linda Rozell-Shannon"

5 Publications

  • Page 1 of 1

Letter to the Editor: Intraosseous Cavernous Hemangioma of the Middle Turbinate: A Case Report.

Ear Nose Throat J 2021 Apr 13:1455613211009132. Epub 2021 Apr 13.

460280The Vascular Birthmark Foundation, Latham, NY, USA.

View Article and Find Full Text PDF

Download full-text PDF

Source
http://dx.doi.org/10.1177/01455613211009132DOI Listing
April 2021

Assessing the impact of COVID-19 on individuals and families affected by vascular anomalies: The VBF COVID-19 survey.

J Plast Reconstr Aesthet Surg 2021 05 13;74(5):1101-1160. Epub 2020 Dec 13.

Vascular Birthmarks Foundation (VBF), VBF Europe Co-Director; VBF Italy Medical Director (VBF Italy, Milan, Italy), VBF, Milan, Italy. Electronic address:

View Article and Find Full Text PDF

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bjps.2020.12.018DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7832352PMC
May 2021

Stop Calling Me Cavernous Hemangioma! A Literature Review on Misdiagnosed Bony Vascular Anomalies.

J Invest Surg 2020 Nov 5:1-10. Epub 2020 Nov 5.

Vascular Birthmark Foundation, New York, USA.

Vascular malformations of the bone most often involve the cranio-facial area. Even in relevant peer reviewed journals, venous malformations are often misdiagnosed as "hemangiomas" or "angiomas" of the bone. By reviewing literature from the past 5 years (2013-2018), we found many reports of vascular malformations of the bone where the diagnosis was incorrect. Unfortunately, there is still much confusion in understanding and/or diagnosing vascular malformations, despite the fact that in recent years many papers tried to clarify this topic. The purpose of this article is to make a review of the scientific literature concerning vascular malformations of the bone which have been reported as angioma, hemangioma, or hemangioendothelioma, and have been published between January 2013 to October 2018. Clinical features, imaging and histologic reports contained in the papers were reviewed. Subsequently, after reviewing every single paper we reclassified the diagnosis according to the 2018 ISSVA classification. Almost all of the vascular anomalies presented in the reviewed papers as angiomas, hemangiomas, or hemangioendotheliomas were venous (mostly) or arteriovenous malformations. Therefore, only 8 out of 58 papers (14.7%) had an accurate diagnosis. Interestingly, all of the papers reporting cavernous or capillary hemangiomas were actually presenting venous malformations. Making a correct diagnosis is of primary importance because depending on the type of vascular anomaly, the treatment and the prognosis for the patient are very different. Everyone who approaches or describes a vascular anomaly of the bone should know and should adopt a correct and updated nosography.
View Article and Find Full Text PDF

Download full-text PDF

Source
http://dx.doi.org/10.1080/08941939.2020.1824041DOI Listing
November 2020

Don't call me "Lymphangioma!"

Oral Maxillofac Surg 2020 09 13;24(3):371-372. Epub 2020 Jun 13.

The Vascular Birthmark Foundation, VBF Europe, VBF Italy, PO Box 106, Latham, NY, 12110, USA.

View Article and Find Full Text PDF

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10006-020-00867-2DOI Listing
September 2020

SECg Staging System: A New Approach to the Management of Arteriovenous Malformations of the Head and Neck.

J Craniofac Surg 2020 Jun;31(4):e420-e424

Lenox Hill Hospital, New York, NY.

Objectives: Arteriovenous malformations (AVM) are the most troublesome vascular malformations to deal with. They tend to behave like low-grade malignancies with infiltrative and disruptive growth. Crucially, the clinical course of an AVM that has been improperly managed is usually characterized by a recurrence that is much more aggressive than the original disease. As in oncology, a comprehensive staging system is highly desirable and is to date lacking in the literature. The authors present a new comprehensive staging system.

Methods: A multicentric multidisciplinary team of experts in the field of vascular anomalies has created this new staging system. The SECg staging system defines the local extension of the disease (S1-S4), the vascular architecture of the malformation (E1, E2, E3), the severity of the symptoms (C0-C3) and the presence or absence of growth of the AVM (g+, g-).

Results: This staging system allows to address all the aspects of AVMs and, more importantly, to help building an appropriate, individualized treatment plan for affected patients. After being staged an AVM can be defined as (a) healable, (b) healable with predicted sequelae, or (c) unhealable. Then, the SECg system allows to outline (a) absolute indications, (b) relative indications, and (c) no indications for treatment. The purpose of the treatment (radical, palliative) is furthermore taken into consideration.

Conclusions: This multicentric, the SECg staging system that this multidisciplinary group of Authors has defined allows for a comprehensive staging of the disease which in turn has enabled to outline an algorithm to properly manage AVMs.
View Article and Find Full Text PDF

Download full-text PDF

Source
http://dx.doi.org/10.1097/SCS.0000000000006446DOI Listing
June 2020